XPhyto Therapeutics Corp. (OTCQB: XPHYF) is a diversified bioscience company focused on next-generation drug delivery, diagnostics, and medical cannabis investment opportunities. CEO Hugh Rogers joins us to discuss the company's competitive advantage in the biotechnology industry, particularly in diagnostic and drug delivery.